Federal contract

AbbVie (ABBV): DoD awarded $21K

DoD awarded AbbVie a contract with $21K committed so far.

$21K
committed so far
Signed
Oct 30, 2025
Updated
Nov 20, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 23, 2024CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
  2. Jan 24, 2025CongressDisclosed sale of ABBV — reported range $1,001 - $15,000
  3. Apr 28, 2025CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
  4. Aug 11, 2025CongressDisclosed partial sale of ABBV — reported range $1,001 - $15,000
  5. Aug 14, 2025CongressDisclosed partial sale of ABBV — reported range $1,001 - $15,000
  6. Aug 22, 2025CongressDisclosed partial sale of ABBV — reported range $1,001 - $15,000
  7. Sep 3, 2025FDAFDA drug approval: Skyrizi
  8. Sep 3, 2025FDAFDA drug approval: Skyrizi
  9. Oct 3, 2025Company filing · Form 8-K · ResultsReported its results
  10. Oct 10, 2025FDAFDA drug approval: Rinvoq
  11. Oct 30, 2025 · this disclosureFederal contract · $21K obligatedDepartment of Defense awarded AbbVie: $21K obligated to date

What came next

  1. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  2. Oct 31, 2025Company filing · Form 8-K · ResultsReported its results
  3. Oct 31, 2025CongressDisclosed sale of ABBV — reported range $1,001 - $15,000
  4. Nov 4, 2025FDAFDA drug approval: Linzess
  5. Nov 10, 2025Layoff notice · 5996 Gleason Drive Dublin CA 94568Layoff notice filed in CA: 48 employees
  6. Nov 10, 2025Layoff notice · 7041 Las Positas Road Livermore CA 94551Layoff notice filed in CA: 9 employees
  7. Nov 10, 2025Layoff notice · 4410 Rosewood Drive Pleasonton CA 94588Layoff notice filed in CA: 2 employees
  8. Nov 13, 2025CongressDisclosed partial sale of ABBV — reported range $1,001 - $15,000
  9. Dec 8, 2025Federal contract · $4K obligatedDepartment of Defense awarded AbbVie: $3.8K obligated to date
  10. Dec 8, 2025CongressDisclosed sale of ABBV — reported range $1,001 - $15,000
  11. Dec 12, 2025Federal contract · $24K obligatedDepartment of Defense awarded AbbVie: $24K obligated to date
  12. Dec 18, 2025FDAFDA drug approval: Vraylar
  13. Dec 18, 2025FDAFDA drug approval: Vraylar
  14. Dec 18, 2025FDAFDA drug approval: Vraylar
  15. Dec 18, 2025FDAFDA drug approval: Vraylar
  16. Dec 18, 2025CongressDisclosed sale of ABBV — reported range $1,001 - $15,000
  17. Dec 22, 2025Government · Federal Register noticeCertain Antibody Drug Conjugates and Components Thereof and Products Containing the Same; Institution of Investigation
  18. Jan 7, 2026Company filing · Form 8-K · ResultsReported its results
  19. Jan 16, 2026FDAFDA device clearance: Natrelle 133S Tissue Expanders
  20. Jan 20, 2026Federal contract · $4K obligatedDepartment of Defense awarded AbbVie: $4K obligated to date
View the official recordUSAspending.gov award record

How to read USAspending.gov award record

The obligated amount is money the government has legally committed to pay and has set aside in its accounts. The ceiling, which USAspending calls the potential value, is the most the contract could be worth if every option is exercised and every possible order is placed. The ceiling is a limit, not a payment, and it is often many times the obligated amount.

Full guide: Contract ceiling vs obligated amount: the difference

What else is on file for AbbVie

For AbbVie, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 3 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABBV page.

How this filing works

Explore the data

Common questions

What federal contract did AbbVie (ABBV) receive?

DoD awarded AbbVie a contract with $21K committed so far. Defense Logistics Agency.

When did it happen, and when was it made public?

Signed: Oct 30, 2025. Updated: Nov 20, 2025.

Is the contract value money the company has received?

No. The award record gives the amount committed so far and a ceiling the contract may reach. Neither is revenue: the company is paid as the work is delivered, and a contract can be cut short.

Where does this information come from?

From the USAspending.gov award record, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about AbbVie recently?

For AbbVie, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 3 fund holdings reports (13F) dated in the last 90 days. They are listed on the ABBV page.

Does this mean ABBV stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at AbbVie

Everything OQRO holds on this company is on its ABBV page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data